GlassScriptPhysician profile
Caryl N Castro
NPI 1194734137
$4,904.35
in general payments reported to CMS, 2019-2025
17 companies · $821 in 2025
The $821 reported for 2025 was more than what 88% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,378 · 2020: $204 · 2021: $445 · 2022: $576 · 2023: $795 · 2024: $685 · 2025: $821.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,302.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,301.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $1,123.16 | 2019-2024 | Misight Contact Lens |
| Bausch & Lomb Americas INC. | $679.36 | 2022-2025 | Miebo, Infuse, Xiidra |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $619.98 | 2019-2021 | |
| Alcon Vision LLC | $491.57 | 2019-2025 | Precision7, Precision 1, Total30 |
| Horizon Therapeutics Plc | $367.61 | 2023 | Tepezza |
| Lkc Technologies, INC. | $246.23 | 2023-2025 | |
| Glaukos Corporation | $242.28 | 2022 | |
| Amgen INC. | $235.24 | 2024-2025 | Tepezza |
| Ocular Therapeutix, INC. | $150.00 | 2025 | Dextenza |
| Biotissue Holdings INC. | $125.00 | 2023 | |
| Abbvie INC. | $124.59 | 2022 | |
| Dompe US, INC. | $120.06 | 2025 | Oxervate |
| Kala Pharmaceuticals, INC. | $118.39 | 2021 | |
| Tarsus Pharmaceuticals, INC. | $93.39 | 2024 | Xdemvy |
| Harrow Eye, LLC | $81.58 | 2025 | Vevye |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Maculogix, INC. | $68.20 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $17.71 | 2025 | Amo Phaco Needle |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caryl Castro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.